MLPH

Molecular Pharmacology (USA), Ltd.

USD

Set alert

Price alert · MLPH

All alert types
0.03 USD 0.00 0.00%
As of Aug 18, 2026
0.0322 Day range 0.0322
0.0002 52-week range 0.485
YTD
+61.00%
1 year
+544.00%
Open
0.0322
Prev close
0.0322
Mkt cap
643.71K
Vol
0
Avg vol
385
EPS
-0.01
P/E
-3.22
More statistics
Low
0.0322
High
0.0322

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for MLPH has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-636.62 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -18.1×
FY 2008: 11.0×FY 2009: -11.0×FY 2010: -18.0×FY 2011: -5.1×FY 2012: -9.5×FY 2013: -5.5×FY 2014: -10.0×FY 2022: -1.0×FY 2023: -0.9×FY 2024: -18.1×
FY 2008 5y median -5.5× FY 2024
P/S 0.0×
FY 2008: 0.0×FY 2009: 0.0×FY 2010: 0.0×FY 2011: 0.0×FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
P/B 0.0×
FY 2008: -0.9×FY 2009: -1.0×FY 2010: -1.4×FY 2011: -0.3×FY 2012: -1.0×FY 2013: -0.6×FY 2014: -0.5×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
P/FCF 0.0×
FY 2008: 34.4×FY 2009: -16.3×FY 2010: -16.1×FY 2011: -4.5×FY 2012: -11.9×FY 2013: -5.9×FY 2014: -10.6×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
EV/EBITDA 0.0×
FY 2008: -6.1×FY 2009: -10.4×FY 2010: -17.2×FY 2011: -4.6×FY 2012: -11.8×FY 2013: -5.8×FY 2014: -9.5×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
EV/Sales 0.0×
FY 2008: 0.0×FY 2009: 0.0×FY 2010: 0.0×FY 2011: 0.0×FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
FCF Yield 0.0%
FY 2008: 2.9%FY 2009: -6.1%FY 2010: -6.2%FY 2011: -22.4%FY 2012: -8.4%FY 2013: -16.8%FY 2014: -9.4%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024

Profitability

Gross Margin 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
ROE 0.0%
FY 2008: -4.4%FY 2009: 7.3%FY 2010: 7.9%FY 2011: 6.2%FY 2012: 8.6%FY 2013: 10.2%FY 2014: 5.2%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
ROIC 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 3852.7%FY 2012: 1723.0%FY 2013: 2230.9%FY 2014: 457.5%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
ROA 0.0%
FY 2008: 180.1%FY 2009: -705.1%FY 2010: -1006.0%FY 2011: -721.5%FY 2012: -2029.0%FY 2013: -1712.6%FY 2014: -1303.8%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 FY 2024
Operating Income 58.4%
FY 2008: 64.9%FY 2009: 40.5%FY 2010: 0.6%FY 2011: -4.0%FY 2012: -47.2%FY 2013: -16.6%FY 2014: 44.1%FY 2022: 0.0%FY 2023: -65.8%FY 2024: 58.4%
FY 2008 FY 2024
EPS (diluted) 100.0%
FY 2008: 123.3%FY 2009: -200.0%FY 2010: 0.0%FY 2011: 0.0%FY 2012: -100.0%FY 2013: 0.0%FY 2014: 50.0%FY 2022: 0.0%FY 2023: -800.0%FY 2024: 100.0%
FY 2008 FY 2024
Free Cash Flow 0.0%
FY 2008: 107.8%FY 2009: -310.8%FY 2010: -66.1%FY 2011: -1.7%FY 2012: -40.2%FY 2013: -15.8%FY 2014: 48.9%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 FY 2024

Financial Health

Current Ratio 0.0×
FY 2008: 1.2×FY 2009: 0.3×FY 2010: 0.5×FY 2011: 0.8×FY 2012: 0.4×FY 2013: 0.6×FY 2014: 0.3×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
Quick Ratio 0.0×
FY 2008: 1.2×FY 2009: 0.3×FY 2010: 0.5×FY 2011: 0.8×FY 2012: 0.4×FY 2013: 0.6×FY 2014: 0.3×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
Debt / Equity 0.0×
FY 2008: 0.0×FY 2009: 0.0×FY 2010: 0.0×FY 2011: 0.0×FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
Net Debt / EBITDA 0.0×
FY 2008: 0.1×FY 2009: 0.1×FY 2010: 0.1×FY 2011: 0.1×FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
Interest Coverage 0.0×
FY 2008: 0.0×FY 2009: 0.0×FY 2010: 0.0×FY 2011: 0.0×FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31